Physician profile
David M Sailors
NPI 1427045517
$7,077.21
in general payments reported to CMS, 2019-2025
39 companies · $907 in 2025
The $907 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $432 · 2021: $320 · 2022: $1,999 · 2023: $548 · 2024: $2,088 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,084 · Travel and Lodging: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,084.36 |
| Travel and Lodging | $1,458.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,565.31 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Endologix LLC | $617.70 | 2023-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System |
| Boston Scientific Corporation | $449.83 | 2019-2024 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $386.13 | 2020-2022 | |
| Angiodynamics, INC. | $334.52 | 2020-2024 | Auryon Laser System 100-120 Vac |
| Organogenesis INC. | $201.95 | 2020-2023 | Puraply |
| Tactile Systems Technology INC | $171.17 | 2020-2022 | |
| Lemaitre Vascular, INC. | $168.08 | 2019-2024 | Artegraft Vascular Graft |
| Kerecis Limited | $138.43 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Venclose INC. | $126.60 | 2019 | |
| Silk Road Medical, INC. | $92.93 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Pfizer INC. | $71.95 | 2019-2023 | |
| Penumbra, INC. | $66.30 | 2023-2025 | Indigo System, Smart Coil, Penumbra System |
| Philips North America LLC | $56.72 | 2019 | |
| Stryker Corporation | $53.05 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $52.82 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Artivion, INC. | $46.83 | 2022 | |
| Cardiva Medical, INC. | $44.82 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $42.11 | 2022-2024 | Artis Pheno |
| Smith+Nephew, INC. | $40.95 | 2023 | Regranex, Collagenase Santyl, Stravix |
| Medtronic, INC. | $36.62 | 2021-2023 | Endurant Iis |
| Bard Peripheral Vascular, INC. | $35.64 | 2020-2021 | |
| Cvrx, INC. | $32.29 | 2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $31.16 | 2020-2022 | |
| Acera Surgical, INC. | $23.90 | 2025 | Restrata Wound Matrix |
| Cagent Vascular INC | $23.70 | 2025 | Serrantor |
| Humacyte Global, INC. | $20.47 | 2025 | Symvess |
| Shockwave Medical, INC | $16.63 | 2025 | |
| Argon Medical Devices, INC. | $15.28 | 2024 | Clot Management |
| Reflow Medical INC | $14.06 | 2025 | |
| Veryan Medical Incorporated | $13.81 | 2022 | |
| Ekos Corporation | $12.73 | 2019 | |
| Amgen INC. | $12.67 | 2021 | |
| Merck Sharp & Dohme LLC | $12.20 | 2020 | |
| Abbott Laboratories | $11.80 | 2021 | |
| Medline Industries LP | $11.69 | 2019 | |
| Medtronic Vascular, INC. | $11.14 | 2019 | |
| Cardiovascular Systems INC. | $8.97 | 2020 | |
| Cashflow Solutions, LLC | $4.25 | 2024 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sailors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.